SLU-PP-332: Research overview, identity, and laboratory handling guide

Small-molecule pan-ERR (estrogen-related receptor) agonist studied in vitro and in animal models for oxidative metabolism research. Research use only. This guide covers identity, published research context, procurement checks, and storage — RUO only, no clinical claims.

What SLU-PP-332 is in published research

SLU-PP-332 is a published small-molecule pan-agonist of the estrogen-related receptor (ERR) family. ERR α, β, and γ are orphan nuclear receptors with established roles in mitochondrial biogenesis and oxidative metabolism. SLU-PP-332 has been studied in vitro in muscle and adipose cell models and in animal exercise-mimetic literature.

Each lot ships with HPLC purity, NMR identity verification where in scope, and a structure summary on the CoA.

Store solid material at -20 °C protected from light and moisture. Prepare working stock in DMSO; final assay buffers should be checked for solubility at the desired working concentration before plating.

CoA + batch records by lot.

The material class "ERR agonist (research compound)" helps procurement teams group SLU-PP-332 with related reference peptides during comparative studies.

Sequence and identity

SLU-PP-332 identity on the catalog: Common name: SLU-PP-332; Class: Pan-ERR (ERRα/β/γ) agonist, small molecule; Molecular weight: Reported on CoA; Appearance: Powder or amorphous solid; Purity (HPLC): ≥ 98%; Solubility: Soluble in DMSO; aqueous solubility limited. Copy these into receiving and LIMS before reconstitution.

Mechanisms studied in published research

Mechanism-focused research on SLU-PP-332 is typically conducted in cell lines or biochemical preparations that express the relevant receptor or binding protein for its class.

Design controls that include scrambled-sequence or orthogonal-receptor negative controls when your protocol evaluates SLU-PP-332 pharmacology in vitro.

Report effect sizes with lot number and CoA reference so results can be reproduced if the same SLU-PP-332 SKU is reordered later.

Avoid extrapolating in vitro binding or signaling readouts to whole-organism outcomes; RUO materials are not qualified for clinical investigation.

Procurement and identity verification

Request the lot-specific CoA for SLU-PP-332 at receipt. Verify SKU, variant size if applicable, and identity mass before the lot enters general storage.

Compare HPLC purity to your internal minimum for the peptide family. File chromatogram excerpts when your QMS requires raw data.

Enter net peptide content from the CoA into inventory before calculating molarity for SLU-PP-332 working stocks.

Attach purchase order, packing list, and CoA in one audit folder per lot.

Storage and reconstitution

Store lyophilized SLU-PP-332 sealed at -20 °C protected from light unless the CoA states otherwise.

Reconstitute with bacteriostatic water or a buffer validated for your assay pH. Aliquot to limit freeze-thaw.

For oxidation-sensitive sequences in SLU-PP-332, minimize open-vial time at room temperature during weighing.

See our lyophilized storage guide for institution-scale SOP examples and aliquot labeling conventions.

Comparative reference points

Researchers comparing SLU-PP-332 with adjacent catalog references often evaluate the following SKUs in parallel plates:

Use matched reconstitution buffers and stock concentrations when running comparative binding or signaling assays.

Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.

When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.

Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.

If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.

Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.

Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.

When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.

Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.

If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.

Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.

Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.

When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.

Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.

If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.

Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.

Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.

When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.

Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.

If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.

Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.

Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.

When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.

Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.

If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.

Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.

Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.

When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.

Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.

If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.

Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.

Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.

When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.

Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.

If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.

Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.

Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.

When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.

Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.

If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.

Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.